TIS 0.00% 0.0¢ tissue therapies limited

EMA Fails to Follow Legislation and Its Own Policy, page-10

  1. 472 Posts.
    lightbulb Created with Sketch. 12
    You're right Figaroo and I'm sorry if my use of language confused anyone. You've caused me to do a bit more research and whereas I am not the font of all European Law I believe I may have found the relevant legislation which has been breached by the EMA in this instance:

    "REGULATION (EC) No 726/2004 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL"

    "AUTHORISATION AND SUPERVISION OF MEDICINAL PRODUCTS FOR HUMAN USE"

    Under Article 6:
    "3. The Agency shall ensure that the opinion of the Committee for Medicinal Products for Human Use is given within 210 days after receipt of a valid application."

    The only outstanding question IMHO is the one raised by Cro as to whether the company requested a delay until February.

    Rev
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.